Dear Friends and Collegues,
Semmelweis University is an internationally well known biomedical university.
The Semmelweis Symposium is organized annually; it is the most prestigious scientific event of the university.
The main topic of the Semmelweis Symposium 2012 is „Principal Questions of Genomic Medicine: Prediction, Prevention and Personalized Treatment”. Personalized medicine is paving the way for a superior health care system. Our rapidly expanding knowledge of genetics and molecular biology is creating a stronger platform for us to move ahead into a future in which care is more closely tailored than ever before. New diagnostics for identifying disorders and new therapeutic possibilities are most likely to obtain their benefits in healthcare. The anticipated arrival of the $1,000 genome this year will accelerate even further the changes that have begun.
The Semmelweis Symposium 2012 is organized by the Prevention Module of the Research Project „Modern Medical Scientific Technologies at the Semmelweis University”. Six research groups all working in different areas of the Personalized Medicine, such as genomics, proteomics, immunomics, cardiology, neurology, neurogenomics and pharmacogenomics invited leading scientists who will show us the spectrum of personalized medicine.
Semmelweis Symposium 2012 provides attendees a wide window into the field of personalized medicine. This meeting will appeal to researchers, PhD students, clinicians, residents, drug/diagnostics developers, and policy regulators.
On behalf of the Organizing Committee, I would like to cordially invite you to the Semmelweis Symposium (November 9-10, 2012, Budapest, Hungary). I look forward to seeing you in Budapest at this exciting scientific conference.
Maria Judit Molnar